Literature DB >> 5643797

Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain.

J Constantinidis, G Bartholini, R Tissot, A Pletscher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5643797     DOI： 10.1007/BF02146939

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  9 in total

1.  THE DIRECT DEMONSTRATION OF A BARRIER MECHANISM IN THE BRAIN CAPILLARIES.

Authors:  A BERTLER; B FALCK; E ROSENGREN
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  STANDARDIZATION OF PARAFORMALDEHYDE AND OF CERTAIN PROCEDURES FOR THE HISTOCHEMICAL DEMONSTRATION OF CATECHOLAMINES.

Authors:  B HAMBERGER; T MALMFORS; C SACHS
Journal:  J Histochem Cytochem       Date:  1965-02       Impact factor: 2.479

3.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

4.  A method for the fluorimetric determination of adrenaline and noradrenaline in tissues.

Authors:  A BERTLER; A CARLSSON; E ROSENGREN
Journal:  Acta Physiol Scand       Date:  1958-12-15

5.  [Selective increase of C14-catecholamines in the brain due to peripheral inhibition of decarboxylase].

Authors:  G Bartholini; A Pletscher; W P Burkard
Journal:  Helv Physiol Pharmacol Acta       Date:  1967

6.  Dopamine formation in brain capillaries--an enzymic blood-brain barrier mechanism.

Authors:  C Owman; E Rosengren
Journal:  J Neurochem       Date:  1967-05       Impact factor: 5.372

7.  The localization of monoaminergic blood-brain barrier mechanisms.

Authors:  A Bertler; B Falck; C Owman; E Rosengrenn
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

Review 8.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

9.  A fluorimetric method for the determination of dopamine (3-hydroxytyramine).

Authors:  A CARLSSON; B WALDECK
Journal:  Acta Physiol Scand       Date:  1958-12-15
  9 in total
  14 in total

1.  Schizophrenia: a theory.

Authors:  E Hartmann
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

4.  Changes in taste under L-DOPA therapy.

Authors:  J Siegfried; H Zumstein
Journal:  Z Neurol       Date:  1971

5.  Formation of noradrenaline in the rat brain from the four stereoisomers of 3,4-dihydroxyphenylserine.

Authors:  M Puig; G Bartholini; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Central decarboxylation and uptake of L-DOPA.

Authors:  N E Andén; J Engel; A Rubenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  Histochemical differentiation of the formaldehyde-induced fluorophores derived from dopamine and L-DOPA.

Authors:  J H Dowson
Journal:  Experientia       Date:  1973-09-15

8.  [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

Authors:  E Schneider; P A Fischer; P Jacobi; H Maxion
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-03-19

9.  The effects of 6-hydroxydopamine pretreatment on the accumulation of dopa and dopamine in brain and peripheral organs following L-dopa administration.

Authors:  L D Lytle; O Hurko; J A Romero; K Cottman; D Leehey; R J Wurtman
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

10.  Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.

Authors:  J Constantinidis; J M Gaillard; F Geissbuhler; R Tissot
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.